Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 14, Pages 5171
Publisher
MDPI AG
Online
2020-07-22
DOI
10.3390/ijms21145171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Protective effect of epigallocatechin gallate on endothelial disorders in atherosclerosis
- (2020) Kazuo Yamagata JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Catechins reduce inflammation in lipopolysaccharide‐stimulated dental pulp cells by inhibiting activation of the NF‐κB pathway
- (2020) Fang Wang et al. ORAL DISEASES
- Adult haemophagocytic lymphohistiocytosis: a review
- (2020) H Yildiz et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients
- (2020) Jose Luis Platero et al. Nutrients
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
- (2020) James T. England et al. BLOOD REVIEWS
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
- (2020) Shengyu Zhang et al. CLINICAL DRUG INVESTIGATION
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis
- (2020) Danica Michaličková et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- HMGB1: A Possible Crucial Therapeutic Target for COVID-19?
- (2020) Maria Elisabeth Street Hormone Research in Paediatrics
- Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
- (2020) Angela Ceribelli et al. JOURNAL OF AUTOIMMUNITY
- Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors
- (2020) Vijay Kumar Bhardwaj et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
- (2020) Zhenwei Yang et al. JOURNAL OF INFECTION
- The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase
- (2020) Jrhau Lung et al. JOURNAL OF MEDICAL VIROLOGY
- Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis
- (2020) Qinghua Fang et al. MEDIATORS OF INFLAMMATION
- Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
- (2020) Ulf Andersson et al. MOLECULAR MEDICINE
- Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
- (2020) Peter M George et al. Lancet Respiratory Medicine
- EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways
- (2020) Ammad Ahmad Farooqi et al. Cancers
- Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients
- (2020) Liting Chen et al. Cellular & Molecular Immunology
- Targeting STAT3 in cancer and autoimmune diseases
- (2020) Tohid Gharibi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review
- (2020) Marzena Wyganowska-Swiatkowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study
- (2020) Rajesh Ghosh et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway
- (2020) Qinhai Ma et al. PHARMACOLOGICAL RESEARCH
- Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
- (2020) Jack Major et al. SCIENCE
- Type III interferons disrupt the lung epithelial barrier upon viral recognition
- (2020) Achille Broggi et al. SCIENCE
- Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
- (2020) Wei Luo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- GREEN TEA: A POSSIBILITY IN THE THERAPEUTIC APPROACH OF INFLAMMATORY BOWEL DISEASES?
- (2019) Sandra Maria Barbalho et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Recent Advances in the Understanding of the Health Benefits and Molecular Mechanisms Associated with Green Tea Polyphenols
- (2019) Lujuan Xing et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability
- (2019) Du et al. Nutrients
- JAK inhibitors for the treatment of autoimmune and inflammatory diseases
- (2019) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Epigallocatechin 3‐gallate attenuates arthritis by regulating Nrf2, HO‐1, and cytokine levels in an experimental arthritis model
- (2019) Ahmet Karatas et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- A cellular and molecular view of T helper 17 cell plasticity in autoimmunity
- (2018) Ralph Stadhouders et al. JOURNAL OF AUTOIMMUNITY
- Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment
- (2018) Stuart J Carter et al. RHEUMATOLOGY
- Antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
- (2018) Kunihiro Kaihatsu et al. MOLECULES
- Transcriptional and chromatin regulation in interferon and innate antiviral gene expression
- (2018) Nancy Au-Yeung et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A Review of the Antiviral Role of Green Tea Catechins
- (2017) et al. MOLECULES
- Chronic Inflammatory Diseases and Green Tea Polyphenols
- (2017) Helieh Oz Nutrients
- Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial
- (2016) Hamed Samavat et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- sn-1,2-diacylglycerols protect against lethal endotoxemia by controlling systemic inflammation
- (2016) Yi-Fu Wang et al. IMMUNOBIOLOGY
- Myeloid-derived NF-κB negative regulation of PU.1 and c/EBP-β-driven pro-inflammatory cytokine production restrains LPS-induced shock
- (2016) Simone Vanoni et al. Innate Immunity
- Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis
- (2016) Jun Pang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans
- (2016) Yuko Momose et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Epigallocatechin-3-gallate ameliorates autoimmune arthritis by reciprocal regulation of T helper-17 regulatory T cells and inhibition of osteoclastogenesis by inhibiting STAT3 signaling
- (2016) Seon-Yeong Lee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2016) Rafael de la Torre et al. LANCET NEUROLOGY
- The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial
- (2016) Cynthia M. Borges et al. Scientific Reports
- Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Faslprmiceviaactivation of cAMP-dependent protein kinase A and inactivation of nuclear factorκB
- (2015) Keiichi Saito et al. AUTOIMMUNITY
- The role of natural killer cells in pathogenesis of autoimmune diseases
- (2015) Katarzyna Popko et al. Central European Journal of Immunology
- Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling
- (2015) Narayanan Sriram et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- New paradigms in sepsis: from prevention to protection of failing microcirculation
- (2015) J. Hawiger et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1
- (2015) Antonia Janssen et al. PLoS One
- A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans
- (2014) Che C. Colpitts et al. JOURNAL OF VIROLOGY
- EGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1α with Th17/Treg Control
- (2014) Eun-Ji Yang et al. PLoS One
- JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
- (2014) B. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct interaction of natural and synthetic catechins with signal transducer activator of transcription 1 affects both its phosphorylation and activity
- (2013) Marta Menegazzi et al. FEBS Journal
- Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure–activity relationship analysis
- (2013) Zi-Feng Yang et al. FITOTERAPIA
- Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4+ T-cell subsets
- (2013) Jae-Kyeong Byun et al. IMMUNOLOGY LETTERS
- Mechanism of the inhibition of the STAT3 signaling pathway by EGCG
- (2013) YANG WANG et al. ONCOLOGY REPORTS
- Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology
- (2013) Conor Mc Guire et al. TRENDS IN MOLECULAR MEDICINE
- Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications
- (2013) Munkyong Pae et al. Food & Function
- Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models
- (2013) Helieh S. Oz et al. Frontiers in Immunology
- Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
- (2012) Thi Thanh Hanh Nguyen et al. BIOTECHNOLOGY LETTERS
- Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea
- (2012) J Steinmann et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
- (2012) Tait D. Shanafelt et al. CANCER
- Effect of 2-Month Controlled Green Tea Intervention on Lipoprotein Cholesterol, Glucose, and Hormone Levels in Healthy Postmenopausal Women
- (2012) A. H. Wu et al. Cancer Prevention Research
- STAT1-DEFICIENT MICE ARE RESISTANT TO CECAL LIGATION AND PUNCTURE–INDUCED SEPTIC SHOCK
- (2012) Daniela Herzig et al. SHOCK
- Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by Epigenetic Regulation
- (2012) Yong Tang et al. STEM CELLS
- Epigallocatechin-3-Gallate Ameliorates Experimental Autoimmune Encephalomyelitis by Altering Balance among CD4+ T-Cell Subsets
- (2011) Junpeng Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages
- (2011) Wei Li et al. BIOCHEMICAL PHARMACOLOGY
- Effects of Green Tea Catechins and Theanine on Preventing Influenza Infection among Healthcare Workers: A Randomized Controlled Trial
- (2011) Keiji Matsumoto et al. BMC Complementary and Alternative Medicine
- (−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
- (2011) Noémie Calland et al. HEPATOLOGY
- Green tea EGCG, T cells, and T cell-mediated autoimmune diseases
- (2011) Dayong Wu et al. MOLECULAR ASPECTS OF MEDICINE
- Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation
- (2011) Katja Herges et al. PLoS One
- The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
- (2011) William G Dixon et al. ARTHRITIS RESEARCH & THERAPY
- Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase
- (2010) Y. Jiang et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases
- (2010) Francesca Danesi et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis
- (2009) Narayanan Sriram et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: A short-term study by pattern electroretinogram
- (2009) Benedetto Falsini et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Bacterial Endotoxin Induces the Release of High Mobility Group Box 1 via the IFN- Signaling Pathway
- (2009) J.-H. Kim et al. JOURNAL OF IMMUNOLOGY
- Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma
- (2009) Irene Paterniti et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Green Tea Polyphenols Ameliorate Pancreatic Injury in Cerulein-Induced Murine Acute Pancreatitis
- (2009) Benoy I. Babu et al. PANCREAS
- Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid
- (2008) Zhi Hua Ran et al. BIOMEDICINE & PHARMACOTHERAPY
- Green Tea Protects Rats against Autoimmune Arthritis by Modulating Disease-Related Immune Events
- (2008) Hong Ro Kim et al. JOURNAL OF NUTRITION
- Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease
- (2008) Kevin Gillespie et al. LIFE SCIENCES
- Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production
- (2008) S. Ahmed et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2–Keap1 signaling
- (2008) Narayanan Sriram et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
- (2007) Valerie Grum-Tokars et al. VIRUS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now